Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with Carboplatin, Paclitaxel, and Cetuximab for SCCHN
NCT01316757Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Feb 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Fox Chase Cancer Center. Started Feb 2011; status: completed.
02
Drugs
erlotinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01316757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316757.